ATE367377T1 - Bis(5-aryl-2-pyridyl)derivate - Google Patents

Bis(5-aryl-2-pyridyl)derivate

Info

Publication number
ATE367377T1
ATE367377T1 AT02736191T AT02736191T ATE367377T1 AT E367377 T1 ATE367377 T1 AT E367377T1 AT 02736191 T AT02736191 T AT 02736191T AT 02736191 T AT02736191 T AT 02736191T AT E367377 T1 ATE367377 T1 AT E367377T1
Authority
AT
Austria
Prior art keywords
formula
pyridyl
aryl
bis
group
Prior art date
Application number
AT02736191T
Other languages
English (en)
Inventor
Hiroyuki Ishiwata
Seiichi Sato
Mototsugu Kabeya
Soichi Oda
Makoto Suda
Manabu Shibasaki
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE367377T1 publication Critical patent/ATE367377T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02736191T 2001-06-29 2002-06-27 Bis(5-aryl-2-pyridyl)derivate ATE367377T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/893,698 US6706703B2 (en) 2001-06-29 2001-06-29 Bis(5-aryl-2-pyridyl) derivatives

Publications (1)

Publication Number Publication Date
ATE367377T1 true ATE367377T1 (de) 2007-08-15

Family

ID=25401924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02736191T ATE367377T1 (de) 2001-06-29 2002-06-27 Bis(5-aryl-2-pyridyl)derivate

Country Status (6)

Country Link
US (2) US6706703B2 (de)
EP (1) EP1403250B1 (de)
JP (1) JP4231404B2 (de)
AT (1) ATE367377T1 (de)
DE (1) DE60221250T2 (de)
WO (1) WO2003002537A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329584D0 (en) * 2003-12-20 2004-01-28 Tanabe Seiyaku Co Novel compounds
US8798933B2 (en) * 2008-10-31 2014-08-05 The Invention Science Fund I, Llc Frozen compositions and methods for piercing a substrate
TW201041868A (en) * 2009-03-20 2010-12-01 Intervet Int Bv Anthelmintic agents and their use
CN113292514B (zh) * 2021-04-07 2022-11-15 浙江华显光电科技有限公司 一种哌嗪衍生物及包含其的有机光电器件

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59167564A (ja) 1983-03-11 1984-09-21 Taiho Yakuhin Kogyo Kk スルホニウム化合物
JPH01106818A (ja) 1987-10-20 1989-04-24 Teijin Ltd 抗アレルギー剤
JP2991897B2 (ja) 1993-06-30 1999-12-20 ハウス食品株式会社 ガゼットタイプの食品充填用包装袋
JPH08109177A (ja) 1994-08-18 1996-04-30 Asahi Chem Ind Co Ltd シクロアルキルアルキルアミン誘導体およびその用途
JP3265134B2 (ja) 1994-09-20 2002-03-11 帝人株式会社 含窒素二環性複素環誘導体およびこれを含有する医薬製剤
KR100365064B1 (ko) 1994-10-17 2003-04-11 훽스트파마슈티칼스앤드케미칼스가부시키가이샤 I형알레르기성질환의예방및치료제
JP4008498B2 (ja) 1996-07-31 2007-11-14 塩野義製薬株式会社 新規パラテルフェニル化合物
AU3866897A (en) * 1996-08-23 1998-03-06 Kowa Co. Ltd. Diamide compounds and drugs containing the same
EP0934924B1 (de) 1996-10-11 2008-08-13 Kowa Co. Ltd. Neue diamidverbindungen und medikamente die diese enthalten
GB9622363D0 (en) * 1996-10-28 1997-01-08 Celltech Therapeutics Ltd Chemical compounds
JPH10324631A (ja) 1997-05-22 1998-12-08 Fujisawa Pharmaceut Co Ltd IgE抗体産生抑制剤
KR100340273B1 (ko) 1997-10-14 2002-06-14 야마모토 카즈모토 비페닐-5-알칸산 유도체 및 이의 용도
AU2516199A (en) 1998-01-12 1999-07-26 Novartis Ag Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors
ID24959A (id) 1998-01-28 2000-08-31 Shionogi & Co Senyawa-senyawa trisiklik yang baru
JP4388228B2 (ja) 1998-02-19 2009-12-24 興和株式会社 環状アミド化合物
JPH11269192A (ja) 1998-03-24 1999-10-05 The Nikka Wisky Distilling Co Ltd フラボン配糖体
EP1101755B1 (de) 1998-07-24 2004-10-06 Teijin Limited Anthranilsäurederivate

Also Published As

Publication number Publication date
EP1403250B1 (de) 2007-07-18
EP1403250A4 (de) 2005-04-13
US20050101634A1 (en) 2005-05-12
EP1403250A1 (de) 2004-03-31
JP4231404B2 (ja) 2009-02-25
DE60221250D1 (de) 2007-08-30
US20030027814A1 (en) 2003-02-06
JPWO2003002537A1 (ja) 2004-10-14
US7196101B2 (en) 2007-03-27
WO2003002537A1 (fr) 2003-01-09
US6706703B2 (en) 2004-03-16
DE60221250T2 (de) 2008-03-20

Similar Documents

Publication Publication Date Title
DE60124504D1 (de) Stabile emulsionszubereitungen
DE60135862D1 (de) Aliphatische stickstoffhaltige fünfgliedrige ringverbindungen
ATE360011T1 (de) Aminoalkoholderivate
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
NO20004485D0 (no) Sykloalkenderivater, deres fremstilling og anvendelse
DE602005027213D1 (de) Neue imidazolidinderivate
DK1447400T3 (da) Bicyklisk forbindelse
FI953710A0 (fi) Uusia pyrrolokarbatsoleja
DK0784055T3 (da) Pyrimidinylpyrazolderivater
DE60130766D1 (de) Serotoninwiederaufnahme-inhibitoren
DE60001487D1 (de) Polynalbuphinderivat
DE60034577D1 (de) In 4-stellung substituierte piperidinderivate
DE60221250D1 (de) Bis(5-aryl-2-pyridyl)derivate
ATE367378T1 (de) Bis(2-aryl-5-pyridyl)derivate
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE318265T1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
DE60224289D1 (de) 1,3-glyceridverbindung mit zwei iodphenylgruppen
TW200626007A (en) Material for electroluminescent element and electroluminescent element
TH14567A (de)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties